Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) --
Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement:
Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/applied-therapeutics-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
WHY? As alleged in a recently filed securities fraud class action complaint, Applied Therapeutics, Inc. (NASDAQ: APLT), through certain of its officers, provided positive statements to investors while, at the same time, disseminating false and materially misleading statements and/or concealing material adverse facts concerning the true state of Applied Therapeutics’ Phase III INSPIRE trial; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study. The Complaint further alleges that such statements absent these material facts caused Plaintiff and other shareholders to purchase Applied Therapeutics’ securities at artificially inflated prices.
On August 25, 2025, the parties reported to the Court that they had agreed to settle the securities fraud class action.
WHAT YOU CAN DO NOW: If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/applied-therapeutics-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $APLT #AppliedTherapeutics
Elevance Health Inc. (NYSE: ELV):
Grabar Law Office is investigating claims on behalf of shareholders of Elevance Health Inc. (NYSE: ELV). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Elevance Health Inc. (NYSE: ELV) shares prior to April 18, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.
Please visit https://grabarlaw.com/the-latest/elevance-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085, to learn more.
WHY? As alleged in a recently filed federal securities fraud class action complaint, Elevance Health Inc. (NYSE: ELV), through certain of its officers, represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. In fact, sicker patients with higher acuity tended to remain on Medicaid after redetermination, leading to higher per-patient costs. This increase in cost was occurring at a rate that was not adequately reflected in Elevance’s rate negotiations with the states or in its financial guidance for 2024. As a result, the Complaint alleges Defendants’ positive statements concerning Elevance’s close monitoring of the redeterminations, the actuarial soundness of its rates and the prudence of its forecasts were materially misleading and/or lacked a reasonable basis.
WHAT YOU CAN DO NOW: If you purchased Elevance Health Inc. (NYSE: ELV) shares prior to April 18, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/elevance-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $ELV #Elevance
LifeMD, Inc. (NASDAQ: LFMD):
The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased LifeMD, Inc. (NASDAQ: LFMD), shares prior to May 7, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Nutex shares between May 7, 2025 and August 5, 2025, you can participate in the class action. You are encouraged to visit https://grabarlaw.com/the-latest/lifemd-shareholder-investigation/ contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.
WHY: As alleged in a recently filed federal securities fraud class action complaint, LifeMD, Inc. (NASDAQ: LFMD), through certain of its officers, made false and/or misleading statements and/or failed to disclose that: (1) Defendants materially overstated LifeMD’s competitive position; (2) Defendants were reckless in raising LifeMD’s 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD’s RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, Defendants’ statements about LifeMD’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
WHAT YOU CAN DO NOW: If you purchased LifeMD, Inc. (NASDAQ: LFMD) shares prior to May 7, 2025, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/lifemd-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased LifeMD shares between May 7, 2025 and August 5, 2025, you can participate in the class action. $LFMD #LifeMD
Quantum Corporation (NASDAQ: QMCO):
Grabar Law Office is investigating claims on behalf of shareholders of Quantum Corporation (NASDAQ: QMCO). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Quantum Corporation (NASDAQ: QMCO) shares prior to November 15, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Pleasec visit https://grabarlaw.com/the-latest/quantum-corp-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. If, alternatively, you purchased or otherwise acquired Quantum Corporation securities between November 15, 2024, and August 18, 2025, inclusive (the “Class Period”), you may participate in the class action.
WHY? As alleged in a recently filed federal securities fraud class action complaint, Quantum Corporation (NASDAQ: QMCO), through certain of its officers, made false and/or misleading statements and/or failed to disclose that: (1) Quantum improperly recognized revenue during the fiscal year ended March 31, 2025; (2) as a result, Quantum would need to restate its previously filed financial statements for the fiscal third quarter ended December 31, 2024; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.
WHAT YOU CAN DO NOW: If you purchased Quantum Corporation (NASDAQ: QMCO) shares prior to November 15, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/quantum-corp-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. If you purchased or otherwise acquired Quantum Corporation securities between November 15, 2024, and August 18, 2025, inclusive (the “Class Period”), you may participate in the class action. $QMCO #QuantumCorp
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
